Variant report
Variant | nsv1000475 |
---|---|
Chromosome Location | chr3:88363069-88403165 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:114)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:88370833-88371190 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr3:88396706-88396908 | A549 | lung: | n/a | chr3:88396754-88396765 |
3 | CEBPB | chr3:88378808-88379094 | IMR90 | lung: | n/a | chr3:88378941-88378952 |
4 | CEBPB | chr3:88378823-88378968 | HepG2 | liver: | n/a | chr3:88378941-88378952 |
5 | CEBPB | chr3:88369030-88369230 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr3:88396623-88396919 | HepG2 | liver: | n/a | chr3:88396754-88396765 |
7 | CEBPB | chr3:88396713-88396914 | Hela-S3 | cervix: | n/a | chr3:88396754-88396765 |
8 | CTCF | chr3:88372984-88373041 | MCF-7 | breast: | n/a | n/a |
9 | CTCF | chr3:88391615-88391656 | HepG2 | liver: | n/a | n/a |
10 | CTCF | chr3:88366722-88366803 | HepG2 | liver: | n/a | n/a |
11 | CTCF | chr3:88366654-88366767 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr3:88366679-88366802 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | CTCF | chr3:88366714-88366804 | GM19238 | blood: | n/a | n/a |
14 | CTCF | chr3:88366673-88366774 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr3:88366689-88366822 | GM12891 | blood: | n/a | n/a |
16 | CTCF | chr3:88366668-88366851 | MCF-7 | breast: | n/a | n/a |
17 | CTCF | chr3:88396440-88396590 | RPTEC | kidney: | n/a | n/a |
18 | CTCF | chr3:88383440-88383590 | HCM | heart: | n/a | n/a |
19 | CTCF | chr3:88383460-88383610 | HPAF | blood vessel: | n/a | n/a |
20 | CTCF | chr3:88366675-88366727 | GM12878 | blood: | n/a | n/a |
21 | CTCF | chr3:88366736-88366740 | GM12878 | blood: | n/a | n/a |
22 | CTCF | chr3:88366721-88366814 | GM13977 | blood: | n/a | n/a |
23 | CTCF | chr3:88366660-88366810 | HepG2 | liver: | n/a | n/a |
24 | CTCF | chr3:88366712-88366739 | Gliobla | brain: | n/a | n/a |
25 | CTCF | chr3:88366639-88366827 | A549 | lung: | n/a | n/a |
26 | CTCF | chr3:88366706-88366789 | ProgFib | skin: | n/a | n/a |
27 | CTCF | chr3:88366691-88366794 | GM12892 | blood: | n/a | n/a |
28 | CTCF | chr3:88366680-88366797 | MCF-7 | breast: | n/a | n/a |
29 | CTCF | chr3:88366675-88366780 | MCF-7 | breast: | n/a | n/a |
30 | CTCF | chr3:88366691-88366812 | HepG2 | liver: | n/a | n/a |
31 | CTCF | chr3:88366726-88366760 | Hela-S3 | cervix: | n/a | n/a |
32 | E2F4 | chr3:88371620-88371836 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | E2F4 | chr3:88396640-88396749 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | E2F4 | chr3:88398054-88398133 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | E2F4 | chr3:88372170-88372370 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr3:88386331-88386647 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr3:88383685-88383962 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | FOS | chr3:88364474-88364507 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | FOS | chr3:88370889-88371094 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | FOS | chr3:88392537-88392768 | MCF10A-Er-Src | breast: | n/a | chr3:88392636-88392643 chr3:88392634-88392643 chr3:88392635-88392644 chr3:88392635-88392643 |
41 | FOS | chr3:88383791-88383970 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | FOS | chr3:88392449-88392766 | MCF10A-Er-Src | breast: | n/a | chr3:88392636-88392643 chr3:88392634-88392643 chr3:88392635-88392644 chr3:88392635-88392643 |
43 | FOS | chr3:88386322-88386690 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | FOS | chr3:88392546-88392820 | MCF10A-Er-Src | breast: | n/a | chr3:88392636-88392643 chr3:88392634-88392643 chr3:88392635-88392644 chr3:88392635-88392643 |
45 | FOS | chr3:88370846-88371132 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | FOS | chr3:88386328-88386635 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | FOS | chr3:88370824-88371125 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | FOS | chr3:88370832-88371125 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | FOS | chr3:88392543-88392730 | MCF10A-Er-Src | breast: | n/a | chr3:88392636-88392643 chr3:88392634-88392643 chr3:88392635-88392644 chr3:88392635-88392643 |
50 | FOSL2 | chr3:88370693-88371198 | MCF-7 | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C3orf38-2 | chr3:88387591-88387793 | XLOC_002727 |
2 | lnc-C3orf38-2 | chr3:88387573-88387793 | XLOC_002727 |
3 | lnc-C3orf38-2 | chr3:88392301-88392435 | NONHSAT090703 |
4 | lnc-C3orf38-2 | chr3:88387572-88387793 | NONHSAT090703 |
5 | lnc-C3orf38-2 | chr3:88392302-88392435 | XLOC_002727 |
6 | lnc-C3orf38-2 | chr3:88387573-88387793 | XLOC_002727 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ABCF2P1 | TF binding region |
VLDLR | miRNA target sites |
E2F8 | miRNA target sites |
BLCAP | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563418538 | chr3:88363350-88363351 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs13089363 | chr3:88363494-88363495 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs528399302 | chr3:88363554-88363555 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs375245491 | chr3:88363572-88363573 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs546443510 | chr3:88363576-88363577 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs367841155 | chr3:88363600-88363601 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs552151684 | chr3:88363601-88363602 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs144601063 | chr3:88364478-88364479 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs528579896 | chr3:88365014-88365015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs6779915 | chr3:88365050-88365051 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs184390410 | chr3:88365062-88365063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147524360 | chr3:88365064-88365065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201987009 | chr3:88365094-88365095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551221199 | chr3:88365116-88365117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12497401 | chr3:88365122-88365123 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs536876614 | chr3:88365131-88365132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554859567 | chr3:88365215-88365216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572640303 | chr3:88365245-88365246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6777497 | chr3:88365285-88365286 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs140187802 | chr3:88365391-88365392 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs190603571 | chr3:88365426-88365427 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs145698089 | chr3:88365435-88365436 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs147661654 | chr3:88365445-88365446 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs115016737 | chr3:88365460-88365461 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs111913995 | chr3:88365461-88365462 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs376952823 | chr3:88365471-88365472 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs148722790 | chr3:88365490-88365491 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs528600757 | chr3:88365516-88365517 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs562991453 | chr3:88365569-88365570 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs547087421 | chr3:88365595-88365596 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs565295621 | chr3:88365614-88365615 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs532584557 | chr3:88365628-88365629 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs142308351 | chr3:88365646-88365647 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs569580263 | chr3:88365665-88365666 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs182077980 | chr3:88365681-88365682 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs12496773 | chr3:88365696-88365697 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs186002213 | chr3:88365709-88365710 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs13092417 | chr3:88365729-88365730 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs373617840 | chr3:88365761-88365762 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs386663257 | chr3:88365786-88365787 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs576351478 | chr3:88365787-88365788 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs368849072 | chr3:88365795-88365796 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs151276314 | chr3:88365833-88365834 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs144432361 | chr3:88365859-88365860 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs73846835 | chr3:88365861-88365862 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs73846836 | chr3:88365862-88365863 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs56203094 | chr3:88365863-88365864 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs200449050 | chr3:88365866-88365867 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs192497880 | chr3:88365869-88365870 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs201396427 | chr3:88365871-88365872 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung cancer | 19547694 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:88365000-88366000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:88370400-88371200 | Enhancers | Hela-S3 | cervix |
3 | chr3:88370600-88370800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr3:88370800-88371000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr3:88371000-88371200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr3:88371200-88371400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr3:88373800-88374800 | Enhancers | HepG2 | liver |
8 | chr3:88374000-88374400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr3:88374200-88374400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
10 | chr3:88383600-88384000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr3:88399800-88400200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |